Annual ROE
-38.42%
-6.10%-18.87%
December 31, 2023
Summary
- As of February 7, 2025, KURA annual return on equity is -38.42%, with the most recent change of -6.10% (-18.87%) on December 31, 2023.
- During the last 3 years, KURA annual ROE has fallen by -23.75% (-161.90%).
- KURA annual ROE is now -161.90% below its all-time high of -14.67%, reached on December 31, 2020.
Performance
KURA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-44.09%
-3.66%-9.05%
September 30, 2024
Summary
- As of February 7, 2025, KURA quarterly return on equity is -44.09%, with the most recent change of -3.66% (-9.05%) on September 30, 2024.
- Over the past year, KURA quarterly ROE has dropped by -7.79% (-21.46%).
- KURA quarterly ROE is now -103.65% below its all-time high of -21.65%, reached on September 30, 2021.
Performance
KURA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
KURA ROE Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -18.9% | -21.5% |
3 y3 years | -161.9% | -21.5% |
5 y5 years | -2.3% | -21.5% |
KURA ROE Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -49.2% | at low | -84.6% | at low |
5 y | 5-year | -161.9% | at low | -103.7% | at low |
alltime | all time | -161.9% | +20.7% | -103.7% | +20.2% |
Kura Oncology ROE History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -44.09%(+9.1%) |
Jun 2024 | - | -40.43%(+7.8%) |
Mar 2024 | - | -37.52%(+3.4%) |
Dec 2023 | -38.42%(+18.9%) | -36.30%(+8.2%) |
Sep 2023 | - | -33.54%(+1.6%) |
Jun 2023 | - | -33.01%(+1.1%) |
Mar 2023 | - | -32.64%(+6.1%) |
Dec 2022 | -32.32%(+25.5%) | -30.77%(+5.2%) |
Sep 2022 | - | -29.26%(+7.9%) |
Jun 2022 | - | -27.13%(+6.4%) |
Mar 2022 | - | -25.49%(+6.7%) |
Dec 2021 | -25.75%(+75.5%) | -23.88%(+10.3%) |
Sep 2021 | - | -21.65%(-2.3%) |
Jun 2021 | - | -22.17%(+0.1%) |
Mar 2021 | - | -22.15%(-10.8%) |
Dec 2020 | -14.67% | -24.84%(-19.8%) |
Sep 2020 | - | -30.96%(+2.3%) |
Jun 2020 | - | -30.25%(-0.3%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2020 | - | -30.33%(+1.9%) |
Dec 2019 | -28.86%(-23.1%) | -29.77%(-4.1%) |
Sep 2019 | - | -31.05%(-5.3%) |
Jun 2019 | - | -32.79%(-18.1%) |
Mar 2019 | - | -40.02%(-5.2%) |
Dec 2018 | -37.55%(-15.4%) | -42.21%(-5.8%) |
Sep 2018 | - | -44.83%(-7.9%) |
Jun 2018 | - | -48.66%(-3.4%) |
Mar 2018 | - | -50.38%(-6.5%) |
Dec 2017 | -44.37%(-8.4%) | -53.90%(+0.9%) |
Sep 2017 | - | -53.40%(-3.4%) |
Jun 2017 | - | -55.27%(+16.9%) |
Mar 2017 | - | -47.28%(+14.4%) |
Dec 2016 | -48.46%(+75.8%) | -41.34%(+13.0%) |
Sep 2016 | - | -36.57%(-5.9%) |
Jun 2016 | - | -38.87%(+2.5%) |
Mar 2016 | - | -37.93%(+0.5%) |
Dec 2015 | -27.56% | -37.74%(-11.7%) |
Sep 2015 | - | -42.75% |
FAQ
- What is Kura Oncology annual return on equity?
- What is the all time high annual ROE for Kura Oncology?
- What is Kura Oncology annual ROE year-on-year change?
- What is Kura Oncology quarterly return on equity?
- What is the all time high quarterly ROE for Kura Oncology?
- What is Kura Oncology quarterly ROE year-on-year change?
What is Kura Oncology annual return on equity?
The current annual ROE of KURA is -38.42%
What is the all time high annual ROE for Kura Oncology?
Kura Oncology all-time high annual return on equity is -14.67%
What is Kura Oncology annual ROE year-on-year change?
Over the past year, KURA annual return on equity has changed by -6.10% (-18.87%)
What is Kura Oncology quarterly return on equity?
The current quarterly ROE of KURA is -44.09%
What is the all time high quarterly ROE for Kura Oncology?
Kura Oncology all-time high quarterly return on equity is -21.65%
What is Kura Oncology quarterly ROE year-on-year change?
Over the past year, KURA quarterly return on equity has changed by -7.79% (-21.46%)